Northwest Cancer Centers is a clinical research site located in Dyer, Indiana, United States 46311.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Northwest Cancer Centers has participated in 4 clinical trials with 4 currently active.
Therapeutic areas: Extensive Stage Small Cell Lung Cancer, Platinum-resistant Ovarian Cancer, Refractory Ovarian Carcinoma.
Sponsors: Shanghai Henlius Biotech, Cybrexa Therapeutics, BioAtla, Inc..
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Northwest Cancer Centers has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Northwest Cancer Centers has 4 clinical trials on record, with 4 currently active. Their work covers Extensive Stage Small Cell Lung Cancer, Platinum-resistant Ovarian Cancer, Refractory Ovarian Carcinoma.
Yes — Northwest Cancer Centers holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.